{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T09:05:30Z","timestamp":1765098330338,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T00:00:00Z","timestamp":1547164800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13052-018-0599-1","type":"journal-article","created":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T06:03:10Z","timestamp":1547186590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Stage 4\u2009s neuroblastoma: features, management and outcome of 268 cases from the Italian Neuroblastoma Registry"],"prefix":"10.1186","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1755-8871","authenticated-orcid":false,"given":"Bruno","family":"De Bernardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Di Cataldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Garaventa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Massirio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Viscardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta Giorgia","family":"Podda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurora","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"D\u2019Angelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Tirtei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fraia","family":"Melchionda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Vetrella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"De Leonardis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmelita","family":"D\u2019Ippolito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Tondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Nonnis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Erminio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Rita","family":"Gigliotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia","family":"Mazzocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Haupt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,11]]},"reference":[{"key":"599_CR1","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/S0140-6736(71)91606-0","volume":"1","author":"GJ D\u2019Angio","year":"1971","unstructured":"D\u2019Angio GJ, Evans AE, Koop C. Special pattern of widespread neuroblastoma with a favorable prognosis. Lancet. 1971;1:1046\u20139.","journal-title":"Lancet"},{"key":"599_CR2","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1200\/JCO.1993.11.8.1466","volume":"11","author":"GM Brodeur","year":"1993","unstructured":"Brodeur GM, Pritchard J, Berthold F, De Bernardi B, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. 1993;11:1466\u201377.","journal-title":"J Clin Oncol"},{"key":"599_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1200\/JCO.2008.16.6785","volume":"27","author":"SL Cohn","year":"2008","unstructured":"Cohn SL, Pearson ADJ, London WB, Monclair T, Ambros PF, Brodeur GM, et al. The international neuroblastoma risk group (INRG) staging system: an INRG task force report. J Clin Oncol. 2008;27:289\u201397.","journal-title":"J Clin Oncol"},{"key":"599_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00441-017-2761-2","volume":"372","author":"GM Brodeur","year":"2018","unstructured":"Brodeur GM. Spontaneous regression of neuroblastoma. Cell Tissue Res. 2018;372:277\u201386.","journal-title":"Cell Tissue Res"},{"key":"599_CR5","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/1097-0142(19800301)45:5<833::AID-CNCR2820450502>3.0.CO;2-U","volume":"45","author":"AE Evans","year":"1980","unstructured":"Evans AE, Chatten J, D\u2019Angio GJ, Gerson JM, Robinson J, Schnaufer L. A review of 17 IV-S neuroblastoma patients at the Children\u2019s hospital of Philadelphia. Cancer. 1980;45:833\u20139.","journal-title":"Cancer"},{"key":"599_CR6","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1002\/1097-0142(19840515)53:10<2083::AID-CNCR2820531014>3.0.CO;2-S","volume":"53","author":"SH Stokes","year":"1984","unstructured":"Stokes SH, Thomas PRM, Perez CA, Vietti TJ. Stage IV-S neuroblastoma: results with definitive therapy. Cancer. 1984;53:2083\u20136.","journal-title":"Cancer"},{"key":"599_CR7","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/1097-0142(19860715)58:2<372::AID-CNCR2820580229>3.0.CO;2-2","volume":"58","author":"SR Stephenson","year":"1986","unstructured":"Stephenson SR, Cook BA, Mease AD, Ruymann FB. The prognostic significance of age and pattern of metastases in stage IV-S neuroblastoma. Cancer. 1986;58:372\u20135.","journal-title":"Cancer"},{"key":"599_CR8","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/mpo.2950190605","volume":"19","author":"A Suarez","year":"1991","unstructured":"Suarez A, Hartmann O, Vassal G, Giron A, Habrand JL, Valteau D, et al. Treatment of stage IV-S neuroblastoma: a study of 34 cases treated between 1982 and 1987. Med Pediatr Oncol. 1991;19:743\u2013477.","journal-title":"Med Pediatr Oncol"},{"key":"599_CR9","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/1097-0142(19920915)70:6<1625::AID-CNCR2820700631>3.0.CO;2-6","volume":"70","author":"B Bernardi De","year":"1992","unstructured":"De Bernardi B, Pianca C, Boni L, Brisigotti M, Carli M, Bagnulo S, et al. Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stage. Italian cooperative group on neuroblastoma. Cancer. 1992;70:1625\u201333.","journal-title":"Cancer"},{"key":"599_CR10","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/00043426-199508000-00007","volume":"17","author":"D Strother","year":"1995","unstructured":"Strother D, Shuster JJ, McWilliams N, Nitschke R, Smith EI, Joshi VJ, et al. Results of pediatric oncology group protocol 8104 for infants with stages D and DS neuroblastoma. J Ped Hematol Oncol. 1995;17:254\u20139.","journal-title":"J Ped Hematol Oncol"},{"key":"599_CR11","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1200\/JCO.1998.16.6.2007","volume":"16","author":"HM Katzenstein","year":"1998","unstructured":"Katzenstein HM, Bowman LC, Brodeur GM, Thorner PS, Joshi VV, Smith EI, et al. Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience. J Clin Oncol. 1998;16:2007\u201317.","journal-title":"J Clin Oncol"},{"key":"599_CR12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1200\/JCO.2000.18.3.477","volume":"18","author":"HJ Nickerson","year":"2000","unstructured":"Nickerson HJ, Matthay KK, Seeger RC, Brodeur GM, Shimada H, Perez C, et al. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer group study. J Clin Oncol. 2000;18:477\u201386.","journal-title":"J Clin Oncol"},{"key":"599_CR13","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/sj.bjc.6601154","volume":"89","author":"G Schleiermacher","year":"2003","unstructured":"Schleiermacher G, Rubie H, Hartmann O, Bergeron C, Chastagner P, Mechinaud F, et al. Neuroblastoma Study Group of the French Society of Paediatric Oncology treatment of stage 4s neuroblastoma \u2013 report of 10 years\u2019 experience of the French Society of Paediatric Oncology (SFOP). Br J Cancer. 2003;89:470\u20136.","journal-title":"Br J Cancer"},{"key":"599_CR14","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.1200\/JCO.2011.35.9570","volume":"29","author":"DR Taggart","year":"2011","unstructured":"Taggart DR, London WB, DuBois SG, Monclair TF, Nakagawara A, De Bernardi B, et al. Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age. J Clin Oncol. 2011;29:4358\u201364.","journal-title":"J Clin Oncol"},{"key":"599_CR15","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/(SICI)1096-911X(199612)27:6<521::AID-MPO3>3.0.CO;2-N","volume":"27","author":"LL Hsu","year":"1996","unstructured":"Hsu LL, Evans AE, D'Angio GJ. Hepatomegaly in neuroblastoma stage 4s: criteria for treatment of the vulnerable neonate. Med Pediatr Oncol. 1996;27:521\u20138.","journal-title":"Med Pediatr Oncol"},{"key":"599_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1055\/s-0043-103086","volume":"229","author":"T Simon","year":"2017","unstructured":"Simon T. GPOH guidelines for diagnosis and treatment of patients with neuroblastic tumors. Klin P\u00e4diatr. 2017;229:147\u201367.","journal-title":"Klin P\u00e4diatr"},{"key":"599_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/BF03260051","volume":"8","author":"P Scaruffi","year":"2004","unstructured":"Scaruffi P, Parodi S, Mazzocco K, Defferrari R, Fontana V, Bonassi S, et al. Detection of MYCN amplification and chromosome 1p36 loss in neuroblastoma by cDNA microarray comparative genomic hybridization. Mol Diagn. 2004;8:93\u2013100.","journal-title":"Mol Diagn"},{"key":"599_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00043426-198721000-00002","volume":"9","author":"GP Tonini","year":"1987","unstructured":"Tonini GP, Verdona G, De Bernardi B, Sansone R, Massimo L, Cornaglia-Ferraris P. N-myc oncogene amplification in a patient with IV-s neuroblastoma. Am J Pediatr Hematol Oncol. 1987;9:8\u201311.","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"599_CR19","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1038\/bjc.1998.370","volume":"77","author":"C Brinkschmidt","year":"1998","unstructured":"Brinkschmidt C, Poremba C, Christiansen H, Simon R, Sch\u00e4fer KL, Terpe HJ, Lampert F, et al. Comparative genomic hybridization and telomerase activity analysis identify 2 biologically different groups of 4s neuroblastomas. Brit J Cancer. 1998;77:2223\u20139.","journal-title":"Brit J Cancer"},{"key":"599_CR20","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1158\/1078-0432.CCR-05-2495","volume":"12","author":"R Spitz","year":"2006","unstructured":"Spitz R, Hero B, Simon T, Berthold F. Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma. Clin Cancer Res. 2006;12:3368\u201373.","journal-title":"Clin Cancer Res"},{"key":"599_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.molonc.2008.07.002","volume":"2","author":"J B\u00e9nard","year":"2008","unstructured":"B\u00e9nard J, Ragu\u00e9nez G, Kauffmann A, Valent A, Ripoche H, Joulin V, et al. MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: a molecular portrait of stage 4S. Mol Oncol. 2008;2:261\u201371.","journal-title":"Mol Oncol"},{"key":"599_CR22","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/bjc.2012.375","volume":"107","author":"G Schleiermacher","year":"2012","unstructured":"Schleiermacher G, Michon J, Ribeiro A, Pierron G, Mosseri V, Rubie H, et al. Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable\/disseminated neuroblastoma (a SIOPEN collaborative study). Br J Cancer. 2012;107:1418\u201322.","journal-title":"Br J Cancer"},{"key":"599_CR23","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1200\/JCO.2009.24.8351","volume":"28","author":"R Haupt","year":"2010","unstructured":"Haupt R, Garaventa A, Gambini C, Parodi S, Cangemi G, De Bernardi B, et al. Improved survival of children with neuroblastoma between 1979 and 2005: a report of the Italian neuroblastoma registry. J Clin Oncol. 2010;28:2331\u20138.","journal-title":"J Clin Oncol"},{"key":"599_CR24","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7","volume":"86","author":"H Shimada","year":"1999","unstructured":"Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, et al. The international neuroblastoma pathology classification (the Shimada system). Cancer. 1999;86:364\u201372.","journal-title":"Cancer"},{"key":"599_CR25","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1200\/JCO.1995.13.4.884","volume":"3","author":"B Bernardi De","year":"1995","unstructured":"De Bernardi B, Conte M, Mancini A, Donfrancesco A, Alvisi P, Tom\u00e0 P, et al. Localized resectable neuroblastoma: results of the second study of the Italian cooperative group for neuroblastoma. J Clin Oncol. 1995;3:884\u201393.","journal-title":"J Clin Oncol"},{"key":"599_CR26","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1200\/JCO.1996.14.5.1537","volume":"14","author":"M Guglielmi","year":"1996","unstructured":"Guglielmi M, De Bernardi B, Rizzo A, Federici S, Poglino C, Siracisa F, et al. Resection of primary tumor at diagnosis in stage IV-S neuroblastoma: does it affect the clinical course? J Clin Oncol. 1996;14:1537\u201344.","journal-title":"J Clin Oncol"},{"key":"599_CR27","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1200\/JCO.2007.14.5839","volume":"27","author":"A Ca\u00f1ete","year":"2009","unstructured":"Ca\u00f1ete A, Gerrard M, Rubie H, Castel V, Di Cataldo A, Munzer C, et al. Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience. J Clin Oncol. 2009;27:1014\u20139.","journal-title":"J Clin Oncol"},{"key":"599_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S1470-2045(12)70012-8","volume":"13","author":"MM Noesel Van","year":"2012","unstructured":"Van Noesel MM. Neuroblastoma stage 4s: a multifocal stem-cell disease of the developing neural crest. Lancet Oncol. 2012;13:229\u201330.","journal-title":"Lancet Oncol"},{"key":"599_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1200\/JCO.1997.15.1.85","volume":"15","author":"GP Tonini","year":"1997","unstructured":"Tonini GP, Boni L, Pession A, Rogers D, Iolascon A, Basso G, et al. MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children. J Clin Oncol. 1997;15:85\u201393.","journal-title":"J Clin Oncol"},{"key":"599_CR30","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1200\/JCO.2007.13.9493","volume":"26","author":"J Schneiderman","year":"2008","unstructured":"Schneiderman J, London WB, Brodeur GM, Castleberry RP, Look AT, Cohn SL. Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblatoma: a report from Children\u2019s oncology group. J Clin Oncol. 2008;26:913\u20138.","journal-title":"J Clin Oncol"},{"key":"599_CR31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000419225","volume":"41","author":"F Berthold","year":"1990","unstructured":"Berthold F, Harms D, Lampert F, Niethammer D, Zieschang G. Risk factors in neuroblastoma of infants. Contrib Oncol. 1990;41:101\u201317.","journal-title":"Contrib Oncol"},{"key":"599_CR32","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/0022-3468(92)90549-M","volume":"27","author":"DA Martinez","year":"1992","unstructured":"Martinez DA, King DR, Ginn-Pease ME, Haase GM, Wiener ES. Resection of the primary tumor is appropriate for children with stage IV-S neuroblastoma: an analysis of 37 patients. J Pediatr Surg. 1992;27:1016\u201320.","journal-title":"J Pediatr Surg"},{"key":"599_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpedsurg.2010.08.064","volume":"46","author":"DJ Keene","year":"2001","unstructured":"Keene DJ, Minford J, Craigie RJ, Humphrey G, Bruce J. Laparostomy closure in stage 4S neuroblastoma. J Pediatr Surg. 2001;46:1\u20134.","journal-title":"J Pediatr Surg"},{"key":"599_CR34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/00043426-200202000-00017","volume":"24","author":"S Roberts","year":"2002","unstructured":"Roberts S, Creamer K, Shoupe B, Flores Y, Robie D. Unique management of stage 4s neuroblastoma complicated by massive hepatomegaly: case report and review of literature. J Pediatr Hematol Oncol. 2002;24:142\u20134.","journal-title":"J Pediatr Hematol Oncol"},{"key":"599_CR35","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/pbc.20080","volume":"43","author":"M Weintraub","year":"2004","unstructured":"Weintraub M, Bloom AI, Gross E, Revel-Vilk S, Shahroor S, Koplewitz BZ, et al. Successful treatment of progressive stage 4s hepatic neuroblastoma in a neonate with intra-arterial chemoembolization. Pediatr Blood Cancer. 2004;43:148\u201351.","journal-title":"Pediatr Blood Cancer"},{"key":"599_CR36","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/pbc.20407","volume":"46","author":"K Boztug","year":"2006","unstructured":"Boztug K, Kiely E, Roebuck DJ, Gaze M, Begent J, Brock P, et al. Successful treatment of MYCN amplified, progressive stage 4S neuroblastoma in a neonate with hepatic artery embolization in addition to multimodality treatment. Pediatr Blood Cancer. 2006;46:253\u20137.","journal-title":"Pediatr Blood Cancer"},{"key":"599_CR37","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/pbc.24391","volume":"60","author":"M Steele","year":"2013","unstructured":"Steele M, Jones NL, Ng V, Kamath B, Avitzur Y, Chami R, et al. Successful liver transplantation in an infant with stage 4S(M) neuroblastoma. Pediatr Blood Cancer. 2013;60:515\u20137.","journal-title":"Pediatr Blood Cancer"},{"key":"599_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/08880018.2016.1266535","volume":"34","author":"T Holsten","year":"2017","unstructured":"Holsten T, Schuster T, Grabhorn E, Hero B, Fruewald MC. Liver transplantation as a potentially lifesaving measure in neuroblastoma stage 4S. Pediatr Hematol Oncol. 2017;34:17\u201323.","journal-title":"Pediatr Hematol Oncol"},{"key":"599_CR39","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/pbc.23186","volume":"59","author":"M Weintraub","year":"2012","unstructured":"Weintraub M, Waldman E, Koplewitz B, Bloom AI, Gross E, Freeman AI, et al. A sequential treatment algorithm for infants with stage 4s neuroblastoma and massive hepatomegaly. Pediatr Blood Cancer. 2012;59:182\u20134.","journal-title":"Pediatr Blood Cancer"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-018-0599-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13052-018-0599-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-018-0599-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T19:03:35Z","timestamp":1578683015000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-018-0599-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,11]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["599"],"URL":"https:\/\/doi.org\/10.1186\/s13052-018-0599-1","relation":{},"ISSN":["1824-7288"],"issn-type":[{"type":"electronic","value":"1824-7288"}],"subject":[],"published":{"date-parts":[[2019,1,11]]},"assertion":[{"value":"14 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The RINB structure and protocol was approved by all the ethics committees of each participating center as a retrospective and prospective observational study. To be enrolled in the RINB, an informed consent form had to be signed by patients\u2019 parents or guardians. For this reason, no specific further consent for this retrospective study needed to be sought. The RINB database is located at the secure Italian Inter-University Consortium CINECA headquarters in Italy, which is 9001:2015 and 27,001:2013 certified. It can be accessed only by authorized users.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"8"}}